Isatuximab and pomalidomide for the treatment of MM
Joseph R. Mikhael
Multiple myeloma highlights from ASCO 2016: monoclonal antibodies and oral proteasome inhibitors
Rigosertib in combination with azacitidine: a potential treatment for AML?
Developments in CML over the past 30 years and where we are today
The explosion of immuno-oncology